Fundraising FoxPrilenia
4 known investors
Find your way into Prilenia
Sign up to see every warm intro you have to Prilenia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prilenia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Prilenia is a biotechnology company developing treatments for neurodegenerative diseases, including Huntington's disease and amyotrophic lateral sclerosis (ALS). Its research centers on pridopidine, a compound that activates the sigma-1 receptor to restore brain pathways affected by neurodegeneration.
Investors · 4
How we know: ALS Investment Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: SV Health Investors's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Prilenia do?
- Prilenia is a biotechnology company developing treatments for neurodegenerative diseases, including Huntington's disease and amyotrophic lateral sclerosis (ALS). Its research centers on pridopidine, a compound that activates the sigma-1 receptor to restore brain pathways affected by neurodegeneration.
- Who are Prilenia's investors?
- Prilenia's investors include ALS Investment Fund, SV Health Investors, Amplitude Venture Capital, Forbion.